首页 | 本学科首页   官方微博 | 高级检索  
检索        

冠心苏合丸系列组方的比较药理学研究
引用本文:马堃,张金艳,李贻奎,张永涛,吴理茂,李向日, 潘理,李连达.冠心苏合丸系列组方的比较药理学研究[J].中国中药杂志,2006,31(16):1353-1357.
作者姓名:马堃  张金艳  李贻奎  张永涛  吴理茂  李向日  潘理  李连达
作者单位:1. 中国中医科学院,西苑医院,北京,100091
2. 浙江大学,药学院,浙江,杭州,310031
3. 北京同仁堂股份有限公司,科学研究所,北京,100011
4. 沈阳中药制药有限公司,辽宁,沈阳,110044
摘    要:目的:研究冠心苏合丸系列组方对急性心肌梗死和疼痛的治疗作用。方法:冠状动脉结扎法制作心肌梗死模型,通过心肌梗死面积的定量组织学测定和血栓素(TXB2)、内皮素(ET)、6-酮-前列腺素(6-keto-PGF1α<1i>)检查、评价冠心苏合丸系列组方治疗心肌梗死的作用;腹腔注射醋酸法制作小鼠疼痛模型,观察小鼠扭体次数和潜伏期,评价其止痛作用。结果:含青木香的冠心苏合丸、含土木香的冠心苏合丸和不含青、土木香的冠心苏合丸显著减小大鼠心肌梗死范围,降低TXB2水平和ET水平;提高6-keto-PGF1α水平和6-keto-PGF1α/ TXB2比值,显著抑制小鼠疼痛;单方青木香和土木香有减缓疼痛的作用。结论:含青木香、含土木香的冠心苏合丸和不含青、土木香的冠心苏合丸对心肌梗死和疼痛均有显著的治疗作用,单方青木香和土木香主要作用是减缓疼痛。

关 键 词:冠心苏合丸系列组方  比较药理学  马兜铃酸  青木香  土木香
文章编号:1001-5302(2006)16-1353-05
收稿时间:2006-04-17
修稿时间:2006-04-17

Study on comparative pharmacology of series of Muskone
MA Kun;ZHANG Jin-yan;LI Yi-kui;ZHANG Yong-tao;WU Li-mao;LI Xiang-ri;PAN Li;LI Lian-da.Study on comparative pharmacology of series of Muskone[J].China Journal of Chinese Materia Medica,2006,31(16):1353-1357.
Authors:MA Kun;ZHANG Jin-yan;LI Yi-kui;ZHANG Yong-tao;WU Li-mao;LI Xiang-ri;PAN Li;LI Lian-da
Institution:1. Xiyuan Hospital, China Academy of Chinese Medical Sciences, Bejing 100700, China; 2. College of Pharmaceutical Sciences, Zhengjiang University, Hangzhou 310031, China ; 3. Tongrentang Technology and Scienoe Ine. Ltd. , Beijing 100011, China; 4. Shengyang Pharmaceutical Co. Ltd., Shenyang 100011, China
Abstract:OBJECTIVE: To study the therapeutic effects of the series of Muskone (the Muskone includes Slender Dutchmanspipe Root, Tumuxiang, and not Slender Dutchmanspipe Root) on experimental myocardial infarct and pain in rats. METHOD: Coronary artery ligation was applied for the model of myocardial infarct. Therapeutic effects were evaluated by measuring parameters of histomorphometry, blood plasm of ET, 6- keto-PGF1alpha and TXB2. Intraperitoneal injection acetic was applied for the model of ache, the frequency and eclipse period of writhing were evaluated its effect of resisting pain. RESULT: The Muskone including Radix Aristolociae, the Muskone including Radix Inulae and the Muskone without Radix Aucklandiae all can decrease the area of myocardial infarction in rats, the level of TXB2, ET, and the frequency of writhing significantly. Also it can increase the level 6-keto-PGF1alpha, the ratio of 6-keto-PGF1alpha and TXB2. Single Radix Aristolociae or Radix Inulae only relieved pain. CONCLUSION: The Muskone including Radix Aristolociae, the Muskone including Radix Inulae and the Muskone without Radix Aucklandiae all have significant therapeutic effect on both myocardial infarction and pain, while single Radix Aristolociae or Radix Inulae only can relieve pain.
Keywords:series of Muskone  comparative pharmacology  aristolochic acid  Radix Aristolociae  Radix Inulae
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号